Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
angiotensinogen | 0.367 | 0.923 | 5.0E-08 |
|
group | 0.600 | None | 0.971 | 77 | 0 | 1979 | 2020 | ||||||||
|
proopiomelanocortin | 0.356 | 0.846 | 1.2E-04 |
|
group | 0.400 | None | 0.989 | 68 | 0 | 1974 | 2020 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.400 | None | 0.973 | 58 | 0 | 1989 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
group | 0.500 | None | 0.975 | 40 | 13 | 1987 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.600 | None | 0.974 | 33 | 0 | 1991 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
group | 0.600 | None | 1.000 | 21 | 0 | 1990 | 2019 | ||||||||
|
KIT proto-oncogene, receptor tyrosine kinase | 0.366 | 0.808 | 0.98 |
|
group | 1.000 | definitive | 0.951 | 19 | 40 | 1995 | 2020 | ||||||||
|
phospholamban | 0.595 | 0.577 | 0.45 |
|
group | 0.700 | definitive | 1.000 | 18 | 3 | 1993 | 2019 | ||||||||
|
renin | 0.370 | 0.923 | 2.4E-07 |
|
group | 0.600 | None | 0.969 | 17 | 0 | 1975 | 2020 | ||||||||
|
amyloid beta precursor protein | 0.422 | 0.846 | 4.7E-02 |
|
group | 0.300 | None | 1.000 | 16 | 0 | 2004 | 2018 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
group | 0.600 | None | 0.984 | 15 | 0 | 1997 | 2019 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
group | 0.600 | None | 0.983 | 14 | 0 | 1993 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
group | 0.500 | None | 0.978 | 14 | 5 | 1988 | 2020 | ||||||||
|
polycystin 1, transient receptor potential channel interacting | 0.493 | 0.769 | 1.00 |
|
group | 0.900 | definitive | 0.976 | 14 | 23 | 1990 | 2019 | ||||||||
|
plasminogen activator, tissue type | 0.445 | 0.885 | 5.7E-05 |
|
group | 0.300 | None | 1.000 | 14 | 0 | 1988 | 2010 | ||||||||
|
mutS homolog 6 | 0.462 | 0.731 | 3.7E-05 |
|
group | 0.640 | definitive | 1.000 | 13 | 283 | 1991 | 2017 | ||||||||
|
interleukin 2 receptor subunit gamma | 0.535 | 0.769 | 0.99 |
|
group | 0.800 | strong | 0.965 | 13 | 40 | 1989 | 2019 | ||||||||
|
checkpoint kinase 2 | 0.460 | 0.808 | 1.2E-24 |
|
group | 0.300 | limited | 1.000 | 12 | 0 | 2003 | 2017 | ||||||||
|
polycystin 2, transient receptor potential cation channel | 0.552 | 0.731 | 1.7E-04 |
|
group | 0.700 | definitive | 0.963 | 12 | 4 | 1996 | 2019 | ||||||||
|
PMS1 homolog 2, mismatch repair system component | 0.484 | 0.808 | 4.5E-27 |
|
group | 0.640 | definitive | 1.000 | 12 | 143 | 1986 | 2018 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
group | 0.500 | None | 0.976 | 12 | 58 | 1976 | 2019 | ||||||||
|
corticotropin releasing hormone | 0.439 | 0.808 | 0.72 |
|
group | 0.400 | None | 1.000 | 11 | 0 | 1994 | 2020 | ||||||||
|
kallikrein related peptidase 3 | 0.443 | 0.885 | 4.4E-06 |
|
group | 0.400 | None | 0.988 | 11 | 0 | 1991 | 2019 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.300 | None | 1.000 | 11 | 0 | 2005 | 2016 | ||||||||
|
methylenetetrahydrofolate reductase | 0.337 | 0.885 | 3.2E-10 |
|
group | 0.300 | None | 1.000 | 11 | 0 | 2005 | 2016 |